Last Updated: Tuesday, August 6, 2013, 21:05
Ranbaxy facilities in India are being reviewed after its US arm admitted to manufacturing certain drugs not in conformity with good manufacturing practices and which are considered "adulterated" under US law, Health Minister Gulam Nabi Azad said Tuesday.